Product Information
FOCALIN 10 MG TABLET is a brand product labeled by Sandoz Inc., priced at $1.3293 per EA under NDC 66758025201. Its NADAC has been published 108 times since Sep 11, 2024.
FDA first approved this application on Nov 13, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the dexmethylphenidate hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Sandoz Inc.NDC
66758025201
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021278FDA Approved
11/13/2001
TE Code
AB
On Market Since
11/30/2001
Pharmacological Classes
Price Statistics
The NADAC for FOCALIN 10 MG TABLET has been published 108 times since Sep 11, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3293 per EA |
|---|---|
| All-time high | $1.3319 (Jun 10, 2026) |
| All-time low | $1.3274 (Oct 22, 2025) |
| 52-week high | $1.3319 |
| 52-week low | $1.3274 |
| Median price | $1.3295 |
| Average price | $1.3294 |
| Largest weekly change | +0.2% (May 20, 2026) |
| Weeks tracked | 108 |
| Tracking since | Sep 11, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dexmethylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FOCALIN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FOCALIN 10 MG TABLET, manufactured by Sandoz Inc., is $1.3293 per EA (NDC 66758025201), effective Sep 30, 2026.
How has the price of FOCALIN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for FOCALIN 10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 108 weekly CMS publications since Sep 11, 2024.
What are the highest and lowest recorded NADAC prices for FOCALIN 10 MG TABLET?
Since Sep 11, 2024, the NADAC for FOCALIN 10 MG TABLET has ranged from a low of $1.3274 (Oct 22, 2025) to a high of $1.3319 (Jun 10, 2026), with a median of $1.3295 per EA.
Are there cheaper alternatives to FOCALIN 10 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXMETHYLPHENIDATE 10 MG TAB, is $0.3414 per EA — about 74% below FOCALIN 10 MG TABLET.
Who manufactures FOCALIN 10 MG TABLET?
FOCALIN 10 MG TABLET (NDC 66758025201) is labeled by Sandoz Inc., and CMS classifies it as a brand product.